Transforming the treatment of luminal disease.*
To fundamentally transform the treatment of luminal diseases using our patented technology for covering stents with collagen derived from amniotic membrane.
Lumens are tubes and chambers found throughout the body, including airways in the lungs, arteries and veins, and the gastrointestinal and urinary tracts. Luminal diseases are conditions that enlarge, restrict or obstruct those lumens. (The first indication FDA clearance will be sought for is tracheobronchial strictures caused by malignant neoplasms.)
"It is the responsibility of those of us involved in today's biomedical research enterprise to translate the remarkable scientific innovations we are witnessing into health gains for the nation. At no other time has the need for robust, bidirectional information flow between basic and translations scientist been so necessary."